Introduction
Malignant tumors are the major malignancy cousing threat to human health. The conventional treatments of cancer include tumorectomy, radiotherapy and chemotherapy. However, these treatments are not effective in curing cancer, or improving the prognosis or lowering the mortality (1) . Molecular biology has advanced greatly, yet there is still no ultimate solution for the biological behavior of malignant tumors, which include unlimited proliferation, differentiation and invasion ability (2) .
Ras gene, as a human oncogene, was the first to be identified in the viral oncogenes of Harvey and Kirsten murine sarcoma viruses (3) . Subsequently, three distinct transforming genes were discovered, and they were present in human-tumor cell lines designated H, K and N-ras (4, 5) , respectively. The Ras protein of transcription and translation might regulate a variety of biological functions including cell growth, differentiation and death (6) . In addition, previous studies showed that tumor malignancies were linked to the Ras protein. However, the mechanisms remain largely undetermined causing the effects of Ras on cancer cells.
In this study, to investigate the underlying mechanisms of repression of activated Ras downregulation tumor cell growth, we extracted gene/protein interactions by bioinformatics and constructed the Ras biologic association network. We confirmed Ras and Hub genes expression in glioma, lung cancer and bladder cancer tissues and inhibition of activated Ras led to repression of U87, T24 and A549 human epithelial tumor cell proliferation and apoptosis induction in vitro. Bioinformatics analysis revealed an association of the Ras network with the Ras signaling pathway. Furthermore, we discovered that downregulation of Ras inhibited several members of this pathway in human epithelial tumor cells.
Materials and methods

Text mining (NLP analysis).
To carry out bioinformatics text mining, we used MEDLINE as the literature source. We queried MEDLINE with: (N-ras or K-ras or H-ras or ras) and (cancer or tumor) and ("1980 Gene ontology analysis. In this experiment, our genes mapped to each node of gene ontology database and the number of genes in these nodes were computed. The software package of GSEABase in the R Project for Statistical Computing (http:// www.r-project.org/) was used. Finally, differentially expressed genes were classified according to three independent modes such as biological process, cellular component and molecular function.
Pathway and gene network analysis. We used GenMAPP v2.1 (GenMAPP -Home Page) to make our genes mapped to KEGG pathway database and to calculate the enrichment p-value of gene in each pathway. We downloaded the pathway data in KEGG database, and used KEGGSOAP software package (http://www.bioconductor.org/packages/2.4/bioc/ html/KEGGSOAP.html) which was in the R Project (http:// www.r-project.org/) to make an assay of the interaction of genes genome-wide, included three connection: ECrel (enzyme-enzyme relation, indicating two enzymes catalyzing successive reaction steps), PPrel (protein-protein interaction, such as binding and modification), GErel (gene expression interaction, indicating relation of transcription factor and target gene product). Considering the results of the three data sets, we integrated it as the network of mutual relations between genes.
Cell culture and treatment. Human U87 glioma cell line, T24 bladder cancer cell line and A549 lung cancer cell line, purchased from the Chinese Academy of Sciences Cell Bank, were grown in DMEM (Gibco USA) and 1640 (Gibco) supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 100 µg/ml streptomycin. The cells were incubated at 37˚C in a humidified atmosphere of 95% air and 5% CO 2 . All cell lines were plated at 10 7 cells per well in 6-well plates and our experiment was separate into three groups: blank group, negative control group treated with DMSO and intervention group treated with FTS (Ras inhibitor, Farnesyl Thiosalicylic Acid, Santa Cruz, USA). RT-PCR analysis. All RNA were extracted from three tumor tissues using TRIzol reagent (Invitrogen) according to the standard protocol, and converted to cDNA by a PCR-kit (AMv) ver.3.0 (Takara). PCR reactions were proceeded with using EZuse Taq polymerase (Generay Biotech, Shanghai, China). In addition, we performed PCR conditions as follows: 95˚C for 30 sec, 58˚C for 30 sec and 72˚C for 60 sec for 30 cycles. The primer sequences are listed in Table I . The PCR products for the gene were electrophoresed on a 2% agarose gel stained with ethideum bromide. Gels were scanned with Gel Doc™XR gel documentation system (Bio-Rad).
Cell proliferation assay. To examine relative cell growth, the MTT assay was prepared. Cells were plated at 10 4 cells per well in 96-well plates, treated with different doses (25, 50, 75 and 100 µM). The number of viable cells was determined with MTT reagent (Keygen, China) post-treatment. The cell viability was measured at 540 nm absorbance using an enzyme-linked immunosorbent assay plate reader. The percent viability was calculated considering the controls as 100%. All data points represent the mean of a minimum of six wells.
Western blot analysis. The total protein was obtained from three human cancer cell lines using RIPA (Applygen, Beijing, China) and the concentration was determined by BCA method (Keygen, China). The lysate was subjected to SDS-PAGE in 10 or 12% acrylamide gel and then transferred to PvDF membranes (Millipore Corp., USA). The membranes were obturated in defatted milk. Next the protein were subjected to immunoblot analysis with one of the following antibodies: anti-PIK3CA, MDM2, CCND1, EGFR, JUN, MYC, vEGFA, ERK1 and ERK2 (Santa Cruz, 1:1,000 dilution).
Apoptosis analysis. The cells were plated in 6-well plates and treated with FTS. After 48 h, according to the manufacturer's instructions, the apoptosis ratio was assayed using Annexin v-FITC Apoptosis Detection kit (BD Biosciences, San Diego, CA, USA) with flow cytometry. Annexin V -and PI -cells were used as controls. Annexin v + and PI -cells were considered as early apoptotic and Annexin v + and PI + cells as late apoptotic and necrotic cells.
Cell cycle analysis. Forty-eight hours after treatment, cells in the log phase of growth were harvested, washed with PBS for three times and fixed with 70% ethanol at -20˚C for 1 h. In addition, next after PBS washing, the cells were suspended in 50 mg/ml propidium iodide (PI) (Sigma-Aldrich) and 20 mg/ml RNaseA (Boehringer-Mannheim), incubated for 1 h at room temperature, and then analyzed by FACScan (Becton-Dickinson, USA). All experiments were performed in triplicate.
Statistical analysis. All tests were done using SPSS Graduate Pack 11.0 statistical software (SPSS, Chicago, IL, USA). Descriptive statistics including mean and SE, along with one-way ANOVA were used to determine significant differences. P<0.05 was considered significant. The biological function of the genes correlated with Ras. The gene ontology database was used. Our genes mapped to each node of GO database and the number of genes in these nodes were computed. The interaction genes of Ras were considered as a whole and displayed in three independent mode, for instance, biological process (Fig. 1A and Table II), cellular component (Fig 1B and Table III ), molecular function (Fig. 1C and Table Iv) . Pathway and gene network analysis. KEGG pathway database was used to count each pathway enrichment p-value. We obtained a total of 128 signaling pathway. In addition, seventeen pathways (Table V) where identified whose corrected p-value was <0.01 and gene count was <10. Subsequently, thirteen cancers (Table vI) were related to this signaling pathway, most of them were human epithelial tumors. The three results of ECrel, PPrel and GErel were integrated into the relationship between gene network. So we created a Ras-related gene network ( Fig. 2A) . Construction of the gene network of Ras-related genes revealed several Hub genes, or genes in which high connection exists giving these genes an influential role in network stability. Generally, the Hub genes which would influence the majority of genes were central to gene regulation, therefore, more important than other genes. Finally, according to their overlaid relationship, we chose top nine (PIK3CA, MDM2, CCND1, EGFR, JUN, MYC, vEGFA, ERK1 and ERK2) whose p-value was <0.05 as the Hub genes (Fig. 2B) . EGFR and vEGFA which were in the upper stream of some pathways could activate the signal transduction pathway. Other genes were all in the middle element of the Ras signaling pathway. 
Results
Identification of Ras interaction genes. For RAS we queried
Primers -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Gene Up Down
The expression of Ras and Hub genes in epithelial tumors.
To explore the expression of RAS in the epithelial tumors, we investigated glioma, lung cancer and bladder cancer tissue samples by semi-quantitative RT-PCR analysis. The expression of RAS mRNA was markedly higher in three tumor tissue specimens. In glioma, compared to normal tissue and low grade gliomas (II), the mRNA level of Ras expression in higher grade gliomas (III and Iv) was remarkably higher. Bladder cancer and lung cancer tissue specimens, contrasted with adjacent non-cancer tissue, the expression of Ras was significantly stronger in the tumor tissues (Fig. 3) . Further, the levels of Hub genes, including PIK3CA, MDM2, CCND1, EGFR, JUN, MYC, vEGFA, ERK1 and ERK2 were higher in their respective tumor tissue.
Inhibition of activated Ras suppresses cell malignancy and inhibits multiple oncogenes in human epithelial tumors.
To study the role of biological behavior of Ras in human epithelial tumor cells, we introduced the Ras inhibitor FTS to inhibit its activity. We examined the effect of FTS on U87, A549 and T24 cell proliferation with different doses. After 48 h, counting of viable cells showed that the inhibitor induced a dose-dependent decrease in cell number (Fig. 4A) . In addition, when the survival rates of cells were ~50%, we considered that the suitable concentration of FTS was 70, 55 and 50 µM, respectively. The epithelial tumor cells from each group were treated with FTS for 48 h, and then the cell cycle was measured by flow cytometry. Cell cycle analysis indicated that FTS significantly caused G1 phase arrest in the epithelial tumor cells compared with the blank group and the negative group (Fig. 4B) . To investigate the biological function of Ras on the apoptosis of the epithelial tumor cells, as shown in Fig. 4C , compared with blank and negative controls, statistically significant more apoptotic cells were found in epithelial tumor cells in activated Ras (P<0.05). The biological behavior of Hub genes involve survival/ apoptosis, proliferation/cell cycle, differentiation and transcription, and appears to play a central role in the etiology and progression of solid tumors. Western blot analysis was used to investigate the relationship between Ras and Hub genes. Inhibition of activated Ras resulted in decreased expression of Hub genes in U87, A549 and T24 cells, respectively (Fig. 5) .
Discussion
In the present study, we confirmed the biological function of interaction genes of Ras through the bioinformatic analysis. Top nine (p<0.05) Hub genes were identified and the pathway and gene network of Ras were established. In addition, then we showed that the expression of Ras and Hub genes in three human epithelial tumor tissues and suppression of activated Ras led to human epithelial tumor cell lines growth suppression and apoptosis increase in vitro. Furthermore, we demonstrated suppression of activated Ras inhibited the Ras pathway by blocking multiple oncogenic targets in human epithelial tumor cells.
Malignant tumors, are a major problem of human health. The cells escape the normal growth regulation mechanism by controlling the expression of several genes (7) (8) (9) . Recent studies have showed that approximately one third of all human cancers, including glioma, lung cancer and bladder cancer, express a constitutively active oncogenic Ras. Abnormal activation of Ras triggers series of physiopathological changes and oncogenesis (10) . In summary, the relationship between Ras and tumors remains unclear. Gene/protein interaction relationship provides us with a comprehensive understanding of biological processes (11) . The accumulation of a large number of biomedical literature is an untapped biological information database for the study of gene/protein interaction networks to provide a reliable data source (12, 13) . Here, we show the tumor biological signaling networks related to the development of Ras-related genes and found Ras-related gene expression to participate in biological processes, cellular components, As an answer to the question of whether inhibition of activated Ras led to growth suppression of the human epithelial tumor cell lines, the increased apoptosis was associated with Ras downstream signaling. The Ras inhibitor (FTS) was included in our research. FTS is a synthetic farnesylcysteine mimic. It can not only prevent Ras from anchoring to the membrane, but also prevents Ras from combining with its molecular chaperone by removing it from the membrane (14-16). In addition, FTS promotes the degradation of Ras suspending it in the cytoplasm to reduce the level of activated Ras, which results in reduction of cancer incidence. In this experiment, our results confirmed repression of activated Ras by FTS inducing a reduction of most of the Hub gene proteins. Most of these Hub genes are transcription factors and sometimes kinases, and can regulate proliferation, differentiation, apoptosis, tumorigenesis, and transformation.
Deregulation of the Ras pathway leads to complex multiple signaling cascades that contribute to human malignancies (17, 18) . Ras is therefore considered an appropriate target for cancer therapy (19) . In light of the complexity of the deregulated Ras pathway, it is important to decipher at the molecular level the response of cancer cells to Ras inhibitors that would reregulate it. Recent research (20) (21) (22) has shown that liver neoplasms are delayed in rats if they were fed with identical concentration of FTS every day. The University of Texas MD Anderson Cancer Center has implemented a program of phase I clinical trials of FTS to treat pancreatic cancer and demonstrated that the drug has no overlapping pharmacokinetics with other chemotherapeutic drugs (20) . Balasis et al (23) have acquired great achievements in treating breast cancer combined with FTS in rats.
